CURI CuriosityStream Inc. - Class A Common Stock

NASDAQ · Media · SEC EDGAR'da Görüntüle ↗

$2,62

Fiyat · May 20, 2026

Temel veriler itibarıyla May 14, 2026

52 Haftlık Aralık

$2–$7

6% of range

Analist Derecelendirmesi

CURI Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık

Fiyat

$2.62

Piyasa Değeri

$223M

P/E (TTM)

-34.5

EPS (TTM)

$-0.11

Gelir (TTM)

$72M

Temettü Verimi

9.9%

ROE

-14.1%

D/E Borç/Özsermaye

—

52 Haftlık Aralık

$2 – $7

CURI Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin

10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri

Gelir ve Net Gelir $72M

2019-12-31 → 2025-12-31

Hisse Başına Kâr $-0.11

2020-12-31 → 2025-12-31

Serbest Nakit Akışı $13M

2020-12-31 → 2025-12-31

Marjlar -9.0%

Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?

Metrik

5 Yıllık trend

CURI

Akran Ortalaması

P/E (TTM)

-34.5

42.5

P/S (TTM) (F/S (TTM))

3.1

0.7

P/B (F/D)

5.4

3.7

Price / FCF (Fiyat / Serbest Nakit Akışı)

17.2

—

Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC

Metrik

5 Yıllık trend

CURI

Akran Ortalaması

Operating Margin (Faaliyet Kâr Marjı)

-10.2%

—

Net Profit Margin (Net Kâr Marjı)

-9.0%

-9.3%

ROA

-7.9%

-10.6%

ROE

-14.1%

-22.2%

ROIC

-17.6%

—

Finansal Sağlık Borç, likidite, solventlik — bilanço gücü

Metrik

5 Yıllık trend

CURI

Akran Ortalaması

Current Ratio (Cari Oran)

1.2

0.6

Quick Ratio (Cari Oran)

1.2

—

Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR

Metrik

5 Yıllık trend

CURI

Akran Ortalaması

Revenue YoY (Gelir Yıllık Bazda)

40.1%

—

Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)

-2.8%

—

Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı)

12.6%

—

Hisse Başı Metrikler Hisse Başı Kâr, hisse başına defter değeri, hisse başına nakit akışı, hisse başına temettü

Metrik

5 Yıllık trend

CURI

Akran Ortalaması

EPS (Diluted) (Hisse Başına Kar (Seyreltilmiş))

$-0.11

—

Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı

Metrik

5 Yıllık trend

CURI

Akran Ortalaması

Payout Ratio (Temettü Ödeme Oranı)

-342.5%

—

Temettüler Temettü verimi, ödeme oranı, temettü geçmişi, 5 Yıllık CAGR

Temettü Verimi

9.9%

Temettü Ödeme Oranı

-342.5%

5 Yıllık Temettü CAGR

—

Ex-tarihi	Miktar
06 Mart 2026	$0,0800
05 Aralık 2025	$0,0800
05 Eylül 2025	$0,0800
13 Haziran 2025	$0,1000
06 Haziran 2025	$0,0800
14 Mart 2025	$0,0400
11 Ekim 2024	$0,0250
12 Temmuz 2024	$0,0250
11 Nisan 2024	$0,0250

CURI Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel

AL 10 analist

Güçlü Al 4 40,0%
Al 5 50,0%
Tut 1 10,0%
Sat 0 0,0%
Güçlü Sat 0 0,0%

12 Aylık Fiyat Hedefi

3 analist · 2026-05-16

Medyan $6.00

← Tüm hedeflerin altında $2.62

Düşük $5.00

Yüksek $7.00

Medyan hedef $6.00 +129,4%

Ortalama hedef $6.00 +129,4%

Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi

Ort. Sürpriz

-0.01%

Dönem	EPS Gerçek	EPS Tahmin	Sürpriz
31 Mart 2026	$-0.02	$-0.02	-0.00%
31 Aralık 2025	$-0.07	$-0.03	-0.04%
30 Eylül 2025	$-0.06	$-0.03	-0.03%
30 Haziran 2025	$0.01	$0.00	0.01%
31 Mart 2025	$0.01	$-0.02	0.03%

Eş Karşılaştırması Anahtar metrikler sektördeki benzerlerine karşı

Hisse Sembolü	Piyasa Değeri	P/E	Gelir YoY	Net Kar Marjı	ROE	Brüt Kar Marjı
CURI	$223M	-34.5	40.1%	-9.0%	-14.1%	—
MCS	—	—	3.1%	1.7%	2.8%	—
ANGX	$790M	-4.3	233.2%	-53.0%	1895.5%	—
STRZ	—	—	-1.6%	—	—	—
PODC	$42M	—	20.4%	-12.4%	-42.8%	—
SEAT	—	—	—	—	—	—
LVO	$676M	-116.5	-3.4%	-16.4%	141.1%	—
GAIA	—	-20.2	55.2%	-99.9%	-5.3%	1914.6%
CAST	—	—	—	—	—	—
NFLX	$395.87B	37.1	15.8%	24.3%	42.6%	—

Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı

Gelir Tablosu 13

CURI için Yıllık Gelir Tablosu verileri
Metrik	2025	2024	2023	2022	2021	2020	2019
Revenue	$72M	$51M	$57M	$78M	$71M	$40M	$18M
Cost of Revenue	·	·	·	·	$1M	·	·
SG&A Expense	$34M	$25M	$29M	$37M	$35M	$21M	$14M
Operating Expenses	$79M	$64M	$101M	$133M	$124M	$78M	$63M
Operating Income	$-7M	$-13M	$-44M	$-55M	$-52M	$-39M	$-45M
Pretax Income	$-6M	$-13M	$-48M	$-51M	$-37M	$-48M	$-43M
Income Tax	$14.0K	$132.0K	$506.0K	$367.0K	$360.0K	$179.0K	$142.0K
Net Income	$-6M	$-13M	$-49M	$-51M	$-38M	$-49M	$-43M
EPS (Basic)	$-0.11	$-0.24	$-0.92	$-0.96	$-0.73	$-3.30	·
EPS (Diluted)	$-0.11	$-0.24	$-0.92	$-0.96	$-1.02	$-3.30	·
Shares (Basic)	57,664,000	54,480,000	53,044,000	52,787,000	51,482,000	18,931,000	13,164,675
Shares (Diluted)	57,664,000	54,480,000	53,044,000	52,787,000	51,789,000	18,931,000	13,164,675
EBITDA	$-7M	$-13M	$-44M	$-55M	$-52M	$-38M	·

Bilanço 25

CURI için Yıllık Bilanço verileri
Metrik	2025	2024	2023	2022	2021	2020	2019
Cash & Equivalents	$18M	$8M	$38M	$40M	$15M	$11M	$9M
Short-term Investments	$9M	$24M	$0	$15M	$66M	$22M	$36M
Receivables	$9M	$6M	$5M	$11M	$23M	$7M	$2M
Other Current Assets	$1M	$1M	$2M	$3M	$6M	$4M	$3M
Current Assets	$37M	$40M	$45M	$70M	$113M	$51M	$49M
PP&E (Net)	$404.0K	$520.0K	$727.0K	$1M	$1M	$1M	$1M
PP&E (Gross)	$2M	$2M	$2M	$3M	$3M	$3M	$3M
Accum. Depreciation	$2M	$2M	$2M	$2M	$2M	$2M	$2M
Goodwill	·	·	·	$0	$3M	·	·
Intangibles	·	·	·	$251.0K	$1M	·	·
Other Non-current Assets	$461.0K	$257.0K	$358.0K	$539.0K	$689.0K	$254.0K	$151.0K
Total Assets	$76M	$86M	$101M	$154M	$218M	$89M	$83M
Accounts Payable	$9M	$6M	$5M	$6M	$3M	$4M	$5M
Accrued Liabilities	$12M	$7M	$4M	$8M	$12M	$3M	$2M
Current Liabilities	$30M	$24M	$23M	$31M	$48M	$22M	$18M
Capital Leases	$3M	$4M	$4M	$5M	·	·	·
Other Non-current Liabilities	$470.0K	$496.0K	$651.0K	$622.0K	$2M	$67.0K	·
Total Liabilities	$34M	$28M	$28M	$36M	$56M	$44M	$19M
Common Stock	$5.0K	$5.0K	$5.0K	$5.0K	$5.0K	$4.0K	$1.0K
Paid-in Capital	$378M	$367M	$363M	$359M	$352M	$198M	·
Retained Earnings	$-336M	$-308M	$-290M	$-241M	$-190M	$-153M	$-92M
Treasury Stock	$251.0K	$251.0K	$0	·	·	·	·
Stockholders' Equity	$41M	$58M	$73M	$118M	$162M	$45M	$-91M
Liabilities + Equity	$76M	$86M	$101M	$154M	$218M	$89M	$83M
Shares Outstanding	58,734,000	56,598,000	53,287,000	52,853,000	52,677,000	39,542,000	13,165,000

Nakit Akışı 15

CURI için Yıllık Nakit Akışı verileri
Metrik	2025	2024	2023	2022	2021	2020	2019
D&A	$164.0K	$339.0K	$496.0K	$699.0K	$612.0K	$391.0K	$142.0K
Stock-based Comp	$14M	$7M	$4M	$7M	$7M	$4M	$1M
Deferred Tax	$0	$0	$0	$-4.0K	$4.0K	·	·
Amort. of Intangibles	$15M	$19M	$23M	$39M	$28M	·	·
Other Non-cash	$5M	$14M	$28M	$4M	$-43M	$-10M	·
Operating Cash Flow	$13M	$8M	$-16M	$-40M	$-73M	$-54M	$-45M
CapEx	$102.0K	$0	$5.0K	$130.0K	$351.0K	$367.0K	$767.0K
Investing Cash Flow	$23M	$-31M	$14M	$63M	$-75M	$25M	$-9M
Stock Issued	·	·	·	·	$94M	·	·
Stock Repurchased	$0	$251.0K	$0	·	·	·	·
Net Stock Activity	$0	$-251.0K	·	·	$94M	·	·
Dividends Paid	$22M	$4M	$0	·	·	·	·
Financing Cash Flow	$-26M	$-7M	$-123.0K	$-218.0K	$148M	$37M	·
Taxes Paid	$-17.0K	$9.0K	$195.0K	$614.0K	$269.0K	$253.0K	$44.0K
Free Cash Flow	$13M	$8M	$-16M	$-40M	$-74M	$-54M	·

Kârlılık 7

CURI için Yıllık Kârlılık verileri
Metrik	2025	2024	2023	2022	2021	2020	2019
Operating Margin	-10.2%	-26.1%	-78.2%	-70.8%	-73.6%	-97.9%	·
Net Margin	-9.0%	-25.3%	-86.0%	-65.2%	-52.8%	-122.7%	·
Pretax Margin	-8.9%	-25.1%	-85.1%	-64.8%	-52.3%	-122.2%	·
EBITDA Margin	-10.0%	-25.4%	-77.3%	-69.9%	-72.8%	-96.5%	·
ROA	-7.9%	-13.8%	-38.3%	-27.4%	-24.6%	-56.8%	·
ROE	-14.1%	-21.6%	-65.4%	-41.0%	-22.6%	155.6%	·
ROIC	-17.6%	-23.3%	-61.9%	-47.3%	-32.7%	-86.6%	·

Likidite ve Solventlik 2

CURI için Yıllık Likidite ve Solventlik verileri
Metrik	Eğilim	2025	2024	2023	2022	2021	2020	2019
Current Ratio		1.2	1.7	1.9	2.2	2.4	2.4	6.7
Quick Ratio		1.2	1.6	1.8	2.1	2.2	1.9	6.0

Verimlilik 2

CURI için Yıllık Verimlilik verileri
Metrik	Eğilim	2025	2024	2023	2022	2021	2020	2019
Asset Turnover		0.9	0.5	0.4	0.4	0.5	0.5	·
Receivables Turnover		9.6	9.4	7.3	4.5	4.6	8.8	·

Hisse Başına 5

CURI için Yıllık Hisse Başına verileri
Metrik	2025	2024	2023	2022	2021	2020	2019
Book Value / Share	$0.71	$1.02	$1.36	$2.23	$4.10	$1.14	·
Revenue / Share	$1.24	$0.94	$1.07	$1.48	$1.38	$2.09	·
Cash Flow / Share	$0.23	$0.15	$-0.30	$-0.75	$-1.41	$-2.83	·
Cash / Share	$0.31	$0.14	$0.71	$0.76	$0.38	$0.28	·
EPS (TTM)	$-0.11	$-0.24	$-0.92	$-0.96	$-1.02	$-3.30	·

Büyüme Oranları 3

CURI için Yıllık Büyüme Oranları verileri
Metrik	2025	2024	2023	2022	2021	2020	2019
Revenue YoY	40.1%	-10.1%	-27.1%	9.5%	79.9%	·	·
Revenue CAGR 3Y	-2.8%	-10.5%	12.8%	·	·	·	·
Revenue CAGR 5Y	12.6%	·	·	·	·	·	·

Değerleme (TTM) 13

CURI için Yıllık Değerleme (TTM) verileri
Metrik	2025	2024	2023	2022	2021	2020	2019
Revenue TTM	$72M	$51M	$57M	$78M	$71M	$40M	$18M
Net Income TTM	$-6M	$-13M	$-49M	$-51M	$-38M	$-49M	$-43M
Market Cap	$223M	$87M	$29M	$60M	$234M	$552M	·
P/E	-34.5	-6.4	-0.6	-1.2	-5.8	-4.2	·
P/S	3.1	1.7	0.5	0.8	3.3	13.9	·
P/B	5.4	1.5	0.4	0.5	1.4	12.3	·
P / Tangible Book	5.4	1.5	0.4	0.5	1.5	12.3	·
P / Cash Flow	17.1	10.6	-1.8	-1.5	-3.2	-10.3	·
P / FCF	17.2	10.6	-1.8	-1.5	-3.2	-10.2	·
Dividend Yield	9.9%	4.7%	0.00%	·	·	·	·
Earnings Yield	-2.9%	-15.7%	-170.4%	-84.2%	-17.2%	-23.7%	·
Payout Ratio	-342.5%	-31.4%	·	·	·	·	·
Annual Payout	$22M	$4M	$0	·	·	·	·

Gelir Tablosu 12

CURI için Çeyreklik Gelir Tablosu verileri
Metrik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Revenue	$15M	$19M	$18M	$19M	$15M	$14M	$13M	$12M	$12M	$15M	$16M	$14M	$12M	$14M	$24M	$22M
SG&A Expense	$7M	$11M	$12M	$6M	$5M	$6M	$6M	$6M	$6M	$6M	$7M	$8M	$8M	$8M	$9M	$11M
Operating Expenses	$17M	$23M	$23M	$19M	$15M	$18M	$16M	$15M	$16M	$20M	$40M	$22M	$20M	$30M	$28M	$38M
Operating Income	$-2M	$-3M	$-4M	$480.0K	$79.0K	$-4M	$-3M	$-3M	$-4M	$-5M	$-24M	$-8M	$-8M	$-15M	$-4M	$-16M
Pretax Income	$-1M	$-3M	$-4M	$669.0K	$347.0K	$-3M	$-3M	$-2M	$-5M	$-5M	$-26M	$-10M	$-8M	$-14M	$-4M	$-16M
Income Tax	$24.0K	$314.0K	$-200.0K	$-100.0K	$28.0K	$-68.0K	$100.0K	$100.0K	$0	$6.0K	$100.0K	$300.0K	$100.0K	$67.0K	$100.0K	$100.0K
Net Income	$-1M	$-4M	$-4M	$784.0K	$319.0K	$-3M	$-3M	$-2M	$-5M	$-5M	$-27M	$-10M	$-8M	$-15M	$-5M	$-16M
EPS (Basic)	$-0.02	$-0.07	$-0.06	$0.01	$0.01	$-0.05	$-0.06	$-0.04	$-0.09	$-0.08	$-0.50	$-0.19	$-0.15	$-0.27	$-0.09	$-0.30
EPS (Diluted)	$-0.02	$-0.07	$-0.06	$0.01	$0.01	$-0.05	$-0.06	$-0.04	$-0.09	$-0.08	$-0.50	$-0.19	$-0.15	$-0.27	$-0.09	$-0.30
Shares (Basic)	58,949,000	-114,983,000	57,930,000	57,585,000	57,132,000	-107,284,000	54,850,000	53,613,000	53,301,000	-105,952,000	53,040,000	53,006,000	52,950,000	-111,525	52,793,000	52,775
Shares (Diluted)	58,949,000	-114,983,000	57,930,000	57,585,000	57,132,000	-107,284,000	54,850,000	53,613,000	53,301,000	-105,952,000	53,040,000	53,006,000	52,950,000	-111,525	52,793,000	52,775
EBITDA	$-2M	·	·	$480.0K	$120.0K	·	$-3M	$-3M	$-4M	·	$-24M	$-8M	$-8M	·	$-4M	$-16M

Bilanço 25

CURI için Çeyreklik Bilanço verileri
Metrik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Cash & Equivalents	$17M	$18M	$14M	$7M	$9M	$8M	$10M	$40M	$39M	$38M	$40M	$44M	$49M	$40M	$47M	$23M
Short-term Investments	$3M	$9M	$14M	$21M	$24M	$24M	$24M	·	·	$0	$0	·	$0	$15M	$17M	$55M
Receivables	$6M	$9M	$9M	$11M	$8M	$6M	$4M	$5M	$5M	$5M	$7M	$9M	$10M	$11M	$17M	$12M
Other Current Assets	$1M	$1M	$999.0K	$909.0K	$1M	$1M	$1M	$1M	$2M	$2M	$1M	$2M	$2M	$3M	$2M	$2M
Current Assets	$27M	$37M	$38M	$40M	$43M	$40M	$39M	$46M	$46M	$45M	$49M	$56M	$61M	$70M	$83M	$92M
PP&E (Net)	$371.0K	$404.0K	$415.0K	$448.0K	$485.0K	$520.0K	$492.0K	$561.0K	$639.0K	$727.0K	$822.0K	$911.0K	$1M	$1M	$1M	$1M
PP&E (Gross)	·	$2M	·	·	·	$2M	·	·	·	$2M	·	·	·	$3M	·	·
Accum. Depreciation	·	$2M	·	·	·	$2M	·	·	·	$2M	·	·	·	$2M	·	·
Goodwill	·	·	·	·	·	·	·	·	·	·	·	·	·	$0	·	·
Intangibles	·	·	·	·	·	·	·	·	·	·	·	·	·	·	$283.0K	$316.0K
Other Non-current Assets	$664.0K	$461.0K	$215.0K	$231.0K	$244.0K	$257.0K	$267.0K	$290.0K	$311.0K	$358.0K	$411.0K	$448.0K	$493.0K	$539.0K	$546.0K	$588.0K
Total Assets	$69M	$76M	$75M	$79M	$85M	$86M	$88M	$91M	$95M	$101M	$106M	$133M	$143M	$154M	$175M	$188M
Accounts Payable	$6M	$9M	$3M	$5M	$5M	$6M	$4M	$3M	$3M	$5M	$7M	$6M	$8M	$6M	$8M	$10M
Accrued Liabilities	$13M	$12M	$12M	$9M	$7M	$7M	$5M	$4M	$5M	$4M	$4M	$4M	$3M	$8M	$7M	$10M
Current Liabilities	$29M	$30M	$23M	$24M	$23M	$24M	$21M	$21M	$23M	$23M	$24M	$25M	$26M	$31M	$38M	$48M
Capital Leases	$3M	$3M	$4M	$4M	$4M	$4M	$4M	$4M	$4M	$4M	$4M	$4M	$5M	$5M	$5M	$5M
Other Non-current Liabilities	$554.0K	$470.0K	$447.0K	$539.0K	$483.0K	$496.0K	$691.0K	$901.0K	$562.0K	$651.0K	$675.0K	$668.0K	$655.0K	$622.0K	$866.0K	$699.0K
Total Liabilities	$33M	$34M	$28M	$29M	$27M	$28M	$25M	$26M	$28M	$28M	$29M	$30M	$32M	$36M	$44M	$55M
Common Stock	$5.0K	$5.0K	$5.0K	$5.0K	$5.0K	$5.0K	$5.0K	$5.0K	$5.0K	$5.0K	$5.0K	$5.0K	$5.0K	$5.0K	$5.0K	$5.0K
Paid-in Capital	$379M	$378M	$374M	$369M	$367M	$367M	$367M	$365M	$363M	$363M	$362M	$361M	$360M	$359M	$357M	$356M
Retained Earnings	$-342M	$-336M	$-327M	$-319M	$-309M	$-308M	$-304M	$-300M	$-296M	$-290M	$-285M	$-259M	$-249M	$-241M	$-227M	$-222M
Treasury Stock	$562.0K	$251.0K	$251.0K	$251.0K	$251.0K	$251.0K	$218.0K	$26.0K	·	$0	·	·	·	·	·	·
Stockholders' Equity	$36M	$41M	$47M	$50M	$58M	$58M	$62M	$65M	$67M	$73M	$77M	$103M	$111M	$118M	$130M	$133M
Liabilities + Equity	$69M	$76M	$75M	$79M	$85M	$86M	$88M	$91M	$95M	$101M	$106M	$133M	$143M	$154M	$175M	$188M
Shares Outstanding	59,288,000	58,734,000	58,081,000	57,711,000	56,930,000	56,598,000	55,475,000	53,745,000	53,306,000	53,287,000	53,071,000	53,026,000	52,961,000	52,853,000	52,802,000	52,786,000

Nakit Akışı 13

CURI için Çeyreklik Nakit Akışı verileri
Metrik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
D&A	$41.0K	$42.0K	$39.0K	$42.0K	$41.0K	$54.0K	$75.0K	$93.0K	$117.0K	$126.0K	$121.0K	$122.0K	$127.0K	$126.0K	$132.0K	$232.0K
Stock-based Comp	$2M	$4M	$7M	$2M	$863.0K	$2M	$3M	$1M	$689.0K	$413.0K	$897.0K	$1M	$1M	$2M	$2M	$2M
Amort. of Intangibles	$4M	$4M	$4M	$4M	$4M	$5M	$5M	$5M	$5M	$5M	$5M	$6M	$6M	$10M	$10M	$10M
Other Non-cash	$256.0K	·	·	·	$699.0K	·	·	·	$5M	·	·	·	$49.0K	·	·	·
Operating Cash Flow	$1M	$4M	$4M	$3M	$2M	$3M	$2M	$2M	$666.0K	$-3M	$-3M	$-4M	$-6M	$-9M	$-13M	$-6M
CapEx	$0	$25.0K	$0	$0	$77.0K	$0	$0	$0	$0	$0	$0	$0	$5.0K	$0	$10.0K	$98.0K
Investing Cash Flow	$3M	$6M	$9M	$6M	$2M	$-1M	$-30M	$0	$0	$0	$-992.0K	$0	$15M	$2M	$37M	$4M
Stock Repurchased	$311.0K	$0	$0	$0	$0	$33.0K	$192.0K	·	·	$0	$0	·	·	·	·	·
Net Stock Activity	$-311.0K	·	·	·	·	·	·	·	·	·	·	·	·	·	·	·
Dividends Paid	$5M	$5M	$5M	$10M	$2M	$1M	$1M	$1M	$0	$0	$0	·	·	·	·	·
Financing Cash Flow	$-5M	$-6M	$-6M	$-11M	$-3M	$-3M	$-2M	$-1M	$-6.0K	$-47.0K	$-19.0K	$-31.0K	$-26.0K	$-40.0K	$-17.0K	$-24.0K
Taxes Paid	$61.0K	$180.0K	$-46.0K	$-153.0K	$34.0K	$-62.0K	$21.0K	$52.0K	$-2.0K	$51.0K	$119.0K	$25.0K	$0	$43.0K	$173.0K	$221.0K
Free Cash Flow	$1M	·	·	·	$2M	·	·	·	$666.0K	·	·	·	$-6M	·	·	·

Kârlılık 7

CURI için Çeyreklik Kârlılık verileri
Metrik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Operating Margin	-10.2%	·	·	2.5%	0.52%	·	-25.8%	-20.6%	-30.4%	·	-152.9%	-56.9%	-62.9%	·	-18.6%	-71.8%
Net Margin	-8.8%	·	·	4.1%	2.1%	·	-24.3%	-16.4%	-41.9%	·	-170.0%	-70.4%	-62.6%	·	-19.1%	-71.5%
Pretax Margin	-8.6%	·	·	3.5%	2.3%	·	-23.9%	-15.9%	-41.7%	·	-169.1%	-68.3%	-62.1%	·	-18.8%	-71.2%
EBITDA Margin	-9.9%	·	·	2.5%	0.80%	·	-25.8%	-20.6%	-29.5%	·	-152.9%	-56.9%	-61.9%	·	-18.6%	-71.8%
ROA	-1.7%	·	·	0.92%	0.35%	·	-3.2%	-1.8%	-4.2%	·	-18.9%	-6.2%	-4.5%	·	-2.2%	-7.6%
ROE	-2.8%	·	·	1.4%	0.51%	·	-4.4%	-2.4%	-5.7%	·	-25.6%	-8.4%	-6.0%	·	-3.0%	-10.6%
ROIC	-4.3%	·	·	1.1%	·	·	-5.4%	-3.9%	-5.5%	·	-31.2%	-8.1%	-7.1%	·	-3.4%	-12.1%

Likidite ve Solventlik 2

CURI için Çeyreklik Likidite ve Solventlik verileri
Metrik	Eğilim	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Current Ratio		1.0	·	·	1.7	1.9	·	1.9	2.2	2.0	·	2.0	2.2	2.3	·	2.2	1.9
Quick Ratio		0.9	·	·	1.6	1.8	·	1.8	2.1	1.9	·	1.9	2.1	2.2	·	2.1	1.9

Verimlilik 2

CURI için Çeyreklik Verimlilik verileri
Metrik	Eğilim	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Asset Turnover		0.2	·	·	0.2	0.2	·	0.1	0.1	0.1	·	0.1	0.1	0.1	·	0.1	0.1
Receivables Turnover		2.2	·	·	2.4	2.4	·	2.2	1.8	1.6	·	1.3	1.4	1.1	·	1.5	2.0

Hisse Başına 6

CURI için Çeyreklik Hisse Başına verileri
Metrik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Book Value / Share	$0.61	·	·	$0.86	$1.02	·	$1.12	$1.21	$1.26	·	$1.45	$1.94	$2.10	·	$2.47	$2.52
Revenue / Share	$0.26	·	·	$0.33	$0.26	·	$0.23	$0.23	$0.23	·	$0.29	$265.95	$233.94	·	$0.45	$0.42
Cash Flow / Share	$0.02	·	·	·	$0.03	·	·	·	$0.01	·	·	·	$-119.13	·	·	·
Cash / Share	$0.28	·	·	$0.12	$0.16	·	$0.17	$0.74	$0.73	·	$0.76	$0.84	$0.92	·	$0.89	$0.43
Dividend / Share	$0	·	·	·	·	$0	·	·	·	·	·	·	·	·	·	·
EPS (TTM)	$-0.06	·	$-0.10	$-0.08	$-0.18	·	$-0.69	$-0.82	$-0.93	·	$-0.93	$-0.73	$-0.84	·	$-0.83	$-0.93

Değerleme (TTM) 11

CURI için Çeyreklik Değerleme (TTM) verileri
Metrik	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Revenue TTM	$68M	·	$65M	$59M	$52M	·	$53M	$54M	$54M	·	$66M	$72M	$76M	·	$82M	$74M
Net Income TTM	$-4M	·	$-6M	$-4M	$-10M	·	$-37M	$-44M	$-49M	·	$-49M	$-38M	$-44M	·	$-36M	$-39M
Market Cap	$175M	·	·	$325M	$153M	·	$106M	$61M	$57M	·	$38M	$49M	$71M	·	$77M	$89M
P/E	-49.3	·	-53.0	-70.4	-14.9	·	-2.8	-1.4	-1.2	·	-0.8	-1.3	-1.6	·	-1.8	-1.8
P/S	2.6	·	·	5.5	2.9	·	2.0	1.1	1.1	·	0.6	0.7	0.9	·	0.9	1.2
P/B	4.8	·	·	6.5	2.6	·	1.7	0.9	0.9	·	0.5	0.5	0.6	·	0.6	0.7
P / Tangible Book	4.8	·	6.5	6.5	2.6	·	1.7	0.9	0.9	·	0.5	0.5	0.6	·	0.6	0.7
P / Cash Flow	145.0	·	·	·	79.4	·	·	·	85.6	·	·	·	-11.3	·	·	·
P / FCF	145.0	·	·	·	82.7	·	·	·	85.6	·	·	·	-11.3	·	·	·
Earnings Yield	-2.0%	·	-1.9%	-1.4%	-6.7%	·	-36.1%	-71.9%	-86.9%	·	-131.2%	-78.2%	-62.2%	·	-56.9%	-55.0%
Payout Ratio	-366.1%	·	·	·	713.8%	·	·	·	·	·	·	·	·	·	·	·

Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl

Gelir Tablosu

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Gelir	$72M	$51M	$57M	$78M	$71M
Faaliyet Kâr Marjı %	-10.2%	-26.1%	-78.2%	-70.8%	-73.6%
Net Gelir	$-6M	$-13M	$-49M	$-51M	$-38M
Seyreltilmiş Hisse Başı Kâr	$-0.11	$-0.24	$-0.92	$-0.96	$-1.02

Bilanço

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Cari Oran	1.2	1.7	1.9	2.2	2.4
Cari Oran	1.2	1.6	1.8	2.1	2.2

Nakit Akışı

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Serbest Nakit Akışı	$13M	$8M	$-16M	$-40M	$-74M

Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar

📊

Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.

Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.

CURI Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık

CURI Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin

Hareketli ortalamalar ve bindirmeler

Hacim

Osilatörler

Momentum ve eğilim

10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri

Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?

Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC

Finansal Sağlık Borç, likidite, solventlik — bilanço gücü

Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR

Hisse Başı Metrikler Hisse Başı Kâr, hisse başına defter değeri, hisse başına nakit akışı, hisse başına temettü

Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı

Temettüler Temettü verimi, ödeme oranı, temettü geçmişi, 5 Yıllık CAGR

CURI Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel

12 Aylık Fiyat Hedefi

Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi

Eş Karşılaştırması Anahtar metrikler sektördeki benzerlerine karşı

Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı

Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl

Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar